Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of sedative and analgesic effects of Ketodex vs Fenofol in ERCP
IRCT20160307026950N55Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine, ketamine, propofol and fentanyl in anxiety disorder and None (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Sedative effect and Analgesic effect. Started Dec 2023; status: completed.
02
Drugs
dexmedetomidineketaminepropofolfentanyl
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20160307026950N55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N55.